Original study
Fish oil supplements for prevention of restenosis after coronary angioplasty

https://doi.org/10.1016/0167-5273(92)90059-CGet rights and content

Abstract

We have evaluated the effect of fish oil supplementation in the prevention of restenosis after percutaneous transluminal coronary angioplasty by a randomised trial conducted in 107 patients. The treatment group (n = 58, 96 significant coronary narrowings) received 10 capsules of fish oil (1.8 g eicosapentaenoic acid, 1.2 g docosahexaenoic acid) besides aspirin and calcium blockers, beginning 4.3 (SD 2.9) days before coronary angioplasty. The conventional medical treatment group (n = 49, 81 significant coronary narrowings) received only aspirin and calcium blockers. Enrollment required the presence of angina pectoris and successful dilatation of all significant coronary narrowings.

All patients were followed-up for at least 6 months. Restenosis was identified by symptoms and exercise testing and confirmed by angiography. The incidence of angiographic restenosis was 32% in the fish oil group and 27% in the conventional treatment group. Biochemical investigations showed a greater decrease in serum triglyceride levels in fish oil group as compared to the conventional treatment group. There was no significant difference in the cholesterol levels over the treatment period.

Administration of fish oil in a dose of 3 g per day did not reduce the incidence of early restenosis after coronary angioplasty.

References (29)

  • KM Kent et al.

    Long-term effecacy of percutaneous transluminal coronary angioplasty (PTCA); report from the registry of the National Heart, Lung, and Blood Institute PTCA Registry

    Am J Cardiol

    (1984)
  • AR Gruentzig et al.

    Long-term follow-up after percutaneous transluminal coronary angioplasty, the early Zurich experience

    N Engl J Med

    (1987)
  • K Detre et al.

    Percutaneous transluminal coronary angioplasty in 1985–1986 and 1977–1981

    N Engl J Med

    (1988)
  • SM Ernst et al.

    Long-term angiographic follow-up, cardiac events and survival in patients undergoing percutaneous transluminal coronary angioplasty

    Br Heart J

    (1987)
  • Cited by (53)

    • Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis

      2009, International Journal of Cardiology
      Citation Excerpt :

      Using our pre-specified search methodology we retrieved 670 abstracts, of which 248 were considered potentially suitable (Fig. 1). After full text review, 47 were included in the final analysis (Table 1) [27–70]. Studies were eliminated if they did not meet the a priori inclusion criteria.

    • N-3 polyunsaturated fatty acids in coronary heart disease: A meta-analysis of randomized controlled trials

      2002, American Journal of Medicine
      Citation Excerpt :

      Four studies included patients who had undergone heart transplantation or bypass surgery, and were therefore also excluded. Eleven trials fulfilled our inclusion criteria: 2 of dietary intervention (20,21) and 9 of supplementation with n-3 polyunsaturated fatty acids (15,22–29). There were 7951 patients in the intervention groups and 7855 patients in the control groups (Table 1).

    View all citing articles on Scopus
    View full text